These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33639244)

  • 21. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
    Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
    Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
    Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
    Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
    J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of very-low-dose oral minoxidil 1.25 mg in male androgenetic alopecia.
    Jha AK; Sonthalia S; Zeeshan MD; Vinay K
    J Am Acad Dermatol; 2020 Nov; 83(5):1491-1493. PubMed ID: 32492469
    [No Abstract]   [Full Text] [Related]  

  • 25. Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia.
    Jimenez-Cauhe J; Saceda-Corralo D; Rodrigues-Barata R; Hermosa-Gelbard A; Moreno-Arrones OM; Fernandez-Nieto D; Vaño-Galvan S
    J Am Acad Dermatol; 2019 Aug; 81(2):648-649. PubMed ID: 31054970
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-pulsed Nd:YAG laser in the treatment of facial hypertrichosis during topical minoxidil therapy.
    Benmously Mlika R; Ben Hamida M; Hammami H; Dorbani Ben Thabet I; Rouatbi M; Mokhtar I
    J Cosmet Laser Ther; 2013 Aug; 15(4):217-8. PubMed ID: 23463948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generalized hypertrichosis after treatment with topical minoxidil.
    González M; Landa N; Gardeazabal J; Calderón MJ; Bilbao I; Díaz Pérez JL
    Clin Exp Dermatol; 1994 Mar; 19(2):157-8. PubMed ID: 8050148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infantile generalized hypertrichosis caused by topical minoxidil.
    Rampon G; Henkin C; de Souza PR; Almeida HL
    An Bras Dermatol; 2016; 91(1):87-8. PubMed ID: 26982785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgenetic alopecia: an evidence-based treatment update.
    Varothai S; Bergfeld WF
    Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment.
    Panchaprateep R; Lueangarun S
    Dermatol Ther (Heidelb); 2020 Dec; 10(6):1345-1357. PubMed ID: 32970299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy and tolerability of 5% minoxidil solution (Carexidil®) in male and female androgenetic alopecia: a 6-month open multicentric study].
    Piraccini B; Starace M; Alessandrini A; Guarrera M; Fiorucci MC; Lorenzi S
    G Ital Dermatol Venereol; 2011 Dec; 146(6 Suppl 1):1-8. PubMed ID: 22189834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is topical minoxidil solution effective on androgenetic alopecia in routine daily practice?
    Mapar MA; Omidian M
    J Dermatolog Treat; 2007; 18(5):268-70. PubMed ID: 17917938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
    DeVillez RL; Jacobs JP; Szpunar CA; Warner ML
    Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
    J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial.
    Uzel BPC; Takano GHS; Chartuni JCN; Cesetti MV; Gavioli CFB; Lemes AM; Costa IMC
    Dermatol Ther; 2021 Jan; 34(1):e14622. PubMed ID: 33269529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. There Is a Positive Dose-Dependent Association between Low-Dose Oral Minoxidil and Its Efficacy for Androgenetic Alopecia: Findings from a Systematic Review with Meta-Regression Analyses.
    Gupta AK; Hall DC; Talukder M; Bamimore MA
    Skin Appendage Disord; 2022 Sep; 8(5):355-361. PubMed ID: 36161084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Piggyback-acquired hypertrichosis.
    Farsani TT; Kane MJ; Kane KS
    Pediatr Dermatol; 2014; 31(4):520-2. PubMed ID: 24915767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
    J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five C's of oral therapy.
    Beach RA
    Dermatol Ther; 2018 Nov; 31(6):e12707. PubMed ID: 30246901
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
    Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
    Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.